Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Outlook Therapeutics (OTLK) has a market cap of $45.342 million USD. According to our data, Outlook Therapeutics is ranked No.8132 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $45.34 M |
-24.98%
|
| Dec 31, 2024 | $60.44 M |
-76.02%
|
| Dec 29, 2023 | $0.25 B |
-63.52%
|
| Dec 30, 2022 | $0.69 B |
-20.59%
|
| Dec 31, 2021 | $0.87 B |
4.62%
|
| Dec 31, 2020 | $0.83 B |
120.34%
|
| Dec 31, 2019 | $0.38 B |
-85.25%
|
| Dec 31, 2018 | $2.56 B |
-61.54%
|
| Dec 29, 2017 | $6.65 B |
-56.81%
|
| Dec 30, 2016 | $15.40 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
| Market Cap | = | OTLK Stock Price | * | OTLK Shares Outstanding |
| = | $1.39 | * | 32.62 M | |
| = | $45.34 M |